1099-1050/asset/HEC_centre.gif?v=1&s=0185bf508eda50f535786bfd8e22b47c50d0e4db)
Research Article
RESPONSE TO REGULATORY STRINGENCY: THE CASE OF ANTIPSYCHOTIC MEDICATION USE IN NURSING HOMES
Article first published online: 1 SEP 2011
DOI: 10.1002/hec.1775
Copyright © 2011 John Wiley & Sons, Ltd.
Additional Information
How to Cite
Bowblis, J. R., Crystal, S., Intrator, O. and Lucas, J. A. (2012), RESPONSE TO REGULATORY STRINGENCY: THE CASE OF ANTIPSYCHOTIC MEDICATION USE IN NURSING HOMES. Health Econ., 21: 977–993. doi: 10.1002/hec.1775
Publication History
- Issue published online: 2 JUL 2012
- Article first published online: 1 SEP 2011
- Manuscript Accepted: 14 JUN 2011
- Manuscript Revised: 15 MAY 2011
- Manuscript Received: 8 FEB 2010
Funded by
- Agency for Healthcare Research and Quality. Grant Number: U18-HS016097
- Retirement Research Foundation. Grant Number: RRF 2007–152
- Abstract
- Article
- References
- Cited By
Keywords:
- regulation;
- nursing homes;
- antipsychotics;
- deficiencies
SUMMARY
This paper studies the impact of regulatory stringency, as measured by the statewide deficiency citation rate over the past year, on the quality of care provided in a national sample of nursing homes from 2000 to 2005. The quality measure used is the proportion of residents who are using antipsychotic medication. Although the changing case-mix of nursing home residents accounts for some of the increase in the use of antipsychotics, we find that the use of antipsychotics by nursing homes is responsive to state regulatory enforcement in a manner consistent with the multitasking incentive problem. Specifically, the effect of the regulations is dependent on the degree of complementarity between the regulatory deficiency and the use of antipsychotics. Copyright © 2011 John Wiley & Sons, Ltd.